Hatch Brand/Generic Meetings Will Involve Jeffords' Health Committee
Executive Summary
Senate Judicary Committee Chairman Hatch (R-Utah) hopes to expand the scope of patent reform discussions by including Health Committee Chairman Jeffords (R-Vt.) in the process.
You may also be interested in...
Waxman/Hatch Debate Moves Forward: Generic Biologics Not Ruled Out
A generic approval process for biological product is being recognized as one item for consideration in reform of the Waxman/Hatch Act by the law's key sponsor in the Senate.
Waxman/Hatch Debate Moves Forward: Generic Biologics Not Ruled Out
A generic approval process for biological product is being recognized as one item for consideration in reform of the Waxman/Hatch Act by the law's key sponsor in the Senate.
BIO Wants Waxman/Hatch Reform Isolated From Generic Biologics
BIO hopes that jurisdictional considerations will prevent the Senate Judiciary Committee's discussion of Waxman/Hatch revisions from becoming a forum for arguments over an FDA approval process for generic versions of biological products.